Rectal versus oral diclofenac for relief of perineal pain after episiotomy repair in Enugu, Nigeria: A randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407499773220

Enrollment

276

Registered

2024-07-16

Start date

2024-09-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Oral diclofenac and suppository placebo group

Oral placebo tablet and suppository diclofenac

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Informed consent 2. Uncomplicated singleton pregnancy 3. Cephalic presentation 4. Gestational age at 37-41 weeks 5. Absence of contraindication to vaginal delivery

Exclusion criteria

Exclusion criteria: 1. History of sensitivity to NSAIDs 2. Intact perineum 3. Asthma 4. Gastric or duodenal ulcer 5. Pre-eclampsia/eclampsia 6. Co-existing comorbidities 7. Postpartum haemorrhage 8. Patients with diarrhea disease

Design outcomes

Primary

Measure	Time frame
The mean post-episiotomy wound repair pain score after commencement of diclofenac administration to the participants.	—

Secondary

Measure	Time frame
Commencement of activities like sitting ,walking, urinating, initiation of breast-feeding,side- effects of the drugs based routes of administration, maternal satisfaction.	—

Countries

Nigeria

Contacts

Public ContactTheophilus Nwankwo

Professor

theophilus.nwankwo@unn.edu.ng+2348037511519

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026